PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2024/74 - Uriach / Cooper
Acquired
Assets Cooper Consumer Health SAS
Description
Laxative medication, administered rectally (enema), used to treat children and infants, as well as pregnant or lactating mothers.
Acquiring
Uriach Lusa, S.A.
Description
Active in the commercialization of over-the-counter pharmaceutical products in final doses and in the development and commercialization of health products. The Uriach Group is also present in the online retail distribution of natural products, through “Naturitas”. Naturitas also sells a small number of appliances related to food preparation, kitchen items and household utensils.
Sector
Activity (NACE)
Applicable legislation
Notification thresholds
Type of merger
Cooperation with sector regulators
Status
Ongoing
Type of Investigation
AdC’s decision
Case description

The merger operation consists of the acquisition, by Uriach Lusa, S.A., a subsidiary of Grupo J. Uriach, S.L. (together with its subsidiaries, “Grupo Uriach”), of exclusive control over the Bebegel business (“Target Business”), currently held by Cooper Consumer Health S.A.S..
Timeline
2024-11-06
Uriach Lusa notifies the acquisition of exclusive control over the Bebegel business, currently owned by Cooper Consumer Health.
Click here to see your activities